REBECCA WHITE: Open Payments
NPI 1285386136 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 46 payments from 17 companies in 2025. Trend: 2023 $1,472 · 2024 $1,029 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $295 |
| ABIOMED | 2 | $157 |
| Eisai Inc. | 2 | $150 |
| Lilly USA, LLC | 5 | $90 |
| ABBVIE INC. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| Dexcom, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
Products named: Ozempic, Leqembi, LEQVIO, MOUNJARO, VRAYLAR, SHINGRIX, Rybelsus, Kerendia.
Industry payments across SC — which companies pay providers there.
